uniQure (NASDAQ:QURE) Stock Plunges on Mixed AMT-130 Huntington's Disease Gene Therapy Data
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameuniQure N.V.
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









